home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Regulating Immune Suppression

  November, 14 2007 19:28
your information resource in human molecular genetics
A quartet of papers in the December 2007 issue of Nature Immunology show how white blood cells can produce interleukin 10, a chemical mediator that helps keep the immune response in check. This response is vital in fighting autoimmune conditions such as colitis, multiple sclerosis and arthritis.

Four separate groups led by Christopher Hunter, Daniel Cua, Abdolmohamad Rostami and Mohamed Oukka showed a certain type of lymphocyte can be stimulated by specific immune messenger molecules to produce the immune suppressive factor interleukin 10. The messenger molecules included either interleukin 27 or a combination of interleukin 6 and another type of messenger molecule called transforming growth factor beta. These results suggest that modulating these messenger molecules could increase interleukin 10 concentrations and temper over-active immune responses.

Many autoimmune conditions are exacerbated when immune suppressing factors such as interleukin 10 are lacking. The work described in the current four papers may provide directed means to intervene in these and other severe autoimmune diseases.

Author contacts:

Christopher A. Hunter (University of Pennsylvania, Dept of Pathobiology, Philadelphia, PA)
Email: mailto:chunter@vet.upenn.edu

Daniel Cua (Schering-Plough Biopharma, Palo Alto, MA, USA)
Email: daniel.cua@dnax.org

Abdolmohamad Rostami (Thomas Jefferson University, Philadelphia, PA, USA)
Email: a.m.rostami@jefferson.edu

Mohamed Oukka (BRIGHAM and Women's/CND and Harvard Medical School, Boston, MA, USA)
Email: moukka@rics.bwh.harvard.edu

Abstracts available online:
Paper 1.
Paper 2.
Paper 3.
Paper 4.

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.